Canopy Growth Corp (NASDAQ:CGC) Share Price

Company Profile

Business description
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Contact
1 Hershey Drive
Smiths FallsONK7A 0A8
CAN
T: +1 855 558-9333
https://www.canopygrowth.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
1,128

Recommended

Companies with US exposure are better positioned to benefit from easing prohibition, writes Kristoffer Inton.

Kristoffer Inton | 26 October 2020

Morningstar thinks these companies are well positioned to benefit from one of five key trends during the next decade, writes Susan Dziubinski.

Susan Dziubinski | 01 October 2020

In ten years’ time, you won’t be illegally smoking cannabis, you’ll be legally eating it. Here are some stocks to watch.

Lex Hall | 22 September 2020

Index	Last price	Change	% Change
All Ordinaries	9,271.40	6.30	0.07%
CAC 40	8,421.04	19.86	0.24%
DAX 40	26,449.16	120.83	-0.45%
Dow JONES (US)	53,559.99	9.45	-0.02%
FTSE 100	10,824.26	31.72	0.29%
HKSE	25,520.89	63.90	-0.25%
NASDAQ	26,402.42	138.93	-0.52%
Nikkei 225	66,311.93	93.63	-0.14%
NZX 50 Index	13,917.30	149.12	1.08%
S&P 500	7,711.76	19.23	-0.25%
S&P/ASX 200	9,076.00	10.40	0.11%
SSE Composite Index	3,986.30	34.12	0.86%